Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.

Journal of gastroenterology and hepatology - 1 Mar 2014

Furuta Takahisa, Sugimoto Mitsushige, Kodaira Chise, Nishino Masafumi, Yamade Mihoko, Uotani Takahiro, Sahara Shu, Ichikawa Hitomi, Yamada Takanori, Osawa Satoshi, Sugimoto Ken, Watanabe Hiroshi, Umemura Kazuo

Abstract excerpt

BACKGROUNDS: Quinolone-based regimens have been used as the rescue for eradication of Helicobacter pylori. Sitafloxacin is known to have low minimum inhibitory concentration for H. pylori. Here, we compared two sitafloxacin-based eradication regimens as rescue for the eradication of H. pylori. METHODS: We attempted to eradicate H. pylori in 180 Japanese patients who had never failed in eradication of H. pylori...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amoxicillin
Share to Clarithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Fluoroquinolones

Share to Gastritis

Share to Metronidazole

Share to Proton Pump Inhibitors

Share to Rabeprazole

Source

Identifiers

PMID: 24224808
DOI: 10.1111/jgh.12442

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.PMID 24224808Read ↗

Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.Semantic proximity Read ↗

Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.Semantic proximity Read ↗

Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure.Semantic proximity Read ↗

Update on quinolone-containing rescue therapies for Helicobacter pylori infection.Semantic proximity Read ↗

Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.Semantic proximity Read ↗

Treatment of Helicobacter pylori infection: Where are we now?Semantic proximity Read ↗

Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures.Semantic proximity Read ↗

Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimensSemantic proximity Read ↗

Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.Semantic proximity Read ↗

Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients: a randomised, double-blind, multicentre study.Semantic proximity Read ↗

The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori.Semantic proximity Read ↗

Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication: a clinical study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.